|
FAM21C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.336400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.285800E-02 |
| Normal-vs-Stage2 |
8.955200E-01 |
| Normal-vs-Stage3 |
6.438100E-02 |
| Normal-vs-Stage4 |
5.926600E-01 |
| Stage1-vs-Stage2 |
1.946200E-01 |
| Stage1-vs-Stage3 |
8.23389999999868E-05 |
| Stage1-vs-Stage4 |
3.370300E-02 |
| Stage2-vs-Stage3 |
2.149400E-01 |
| Stage2-vs-Stage4 |
7.766400E-01 |
| Stage3-vs-Stage4 |
2.161400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.435400E-01 |
| Normal-vs-AfricanAmerican |
1.103770E-01 |
| Normal-vs-Asian |
1.740260E-02 |
| Caucasian-vs-AfricanAmerican |
7.981700E-02 |
| Caucasian-vs-Asian |
7.962400E-02 |
| AfricanAmerican-vs-Asian |
2.077400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.973000E-01 |
| Normal-vs-Female |
3.073500E-02 |
| Male-vs-Female |
3.849900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.058800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.584400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.939800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.823000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.486800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.389400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.405400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.343180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.083600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.391400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.436000E-03 |
| Normal-vs-Grade 2 |
1.291370E-01 |
| Normal-vs-Grade 3 |
6.567000E-01 |
| Normal-vs-Grade 4 |
1.329750E-02 |
| Grade 1-vs-Grade 2 |
2.441500E-04 |
| Grade 1-vs-Grade 3 |
3.597100E-03 |
| Grade 1-vs-Grade 4 |
9.197500E-04 |
| Grade 2-vs-Grade 3 |
2.820000E-02 |
| Grade 2-vs-Grade 4 |
4.30100000000655E-05 |
| Grade 3-vs-Grade 4 |
2.042100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.636400E-03 |
| Normal-vs-ccB subtype |
3.842200E-03 |
| ccA subtype-vs-ccB subtype |
1.78839998365987E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.980400E-01 |
| Normal-vs-N1 |
8.259200E-01 |
| N0-vs-N1 |
7.083800E-01 |
|
|
